- Home
- LPCN vs BGI Comparison
LPCN vs BGI Comparison
Compare LPCN & BGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPCN
- BGI
- Stock Information
- Founded
- LPCN 1997
- BGI 1879
- Country
- LPCN United States
- BGI Canada
- Employees
- LPCN N/A
- BGI N/A
- Industry
- LPCN Biotechnology: Pharmaceutical Preparations
- BGI
- Sector
- LPCN Health Care
- BGI
- Exchange
- LPCN Nasdaq
- BGI Nasdaq
- Market Cap
- LPCN 27.1M
- BGI 31.1M
- IPO Year
- LPCN N/A
- BGI 2005
- Fundamental
- Price
- LPCN $4.51
- BGI $1.50
- Analyst Decision
- LPCN Strong Buy
- BGI
- Analyst Count
- LPCN 1
- BGI 0
- Target Price
- LPCN $10.00
- BGI N/A
- AVG Volume (30 Days)
- LPCN 32.3K
- BGI 6.0K
- Earning Date
- LPCN 03-06-2025
- BGI 11-27-2024
- Dividend Yield
- LPCN N/A
- BGI N/A
- EPS Growth
- LPCN N/A
- BGI N/A
- EPS
- LPCN N/A
- BGI N/A
- Revenue
- LPCN $7,922,926.00
- BGI $131,596,264.00
- Revenue This Year
- LPCN N/A
- BGI N/A
- Revenue Next Year
- LPCN N/A
- BGI N/A
- P/E Ratio
- LPCN N/A
- BGI N/A
- Revenue Growth
- LPCN N/A
- BGI 4.01
- 52 Week Low
- LPCN $3.20
- BGI $1.39
- 52 Week High
- LPCN $11.79
- BGI $4.37
- Technical
- Relative Strength Index (RSI)
- LPCN 43.02
- BGI 34.54
- Support Level
- LPCN $4.25
- BGI $1.45
- Resistance Level
- LPCN $4.73
- BGI $1.52
- Average True Range (ATR)
- LPCN 0.33
- BGI 0.06
- MACD
- LPCN -0.04
- BGI 0.00
- Stochastic Oscillator
- LPCN 20.80
- BGI 26.61
About LPCN Lipocine Inc.
Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.
About BGI Birks Group Inc.
Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.